Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis Katsuyoshi Matsuoka, Kanae Togo, Noritoshi Yoshii, Masato Hoshi, Shoko Arai. Intest Res. 2023;21(1):88-89 Although immunosuppressants and biologics are drugs that contribute to improving the prognosis of ulcerative colitis (UC) by inducing mucosal healing, these drugs can cause an increase in opportunistic infections by weakening the host immune responses. In addition, these drugs have the potential to increase the risk of developing malignancies. The present study examined the incidence of hospitalized infections, herpes zoster (HZ), and malignancies in patients with UC, stratified by treatment using Japanese administrative health claims databases. ![]()
Best regards, |